Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents.
Uemura H, Masumori N, Takahashi S, Hosono M, Kinuya S, Sunaya T, Horio T, Okayama Y, Kakehi Y. Uemura H, et al. Among authors: kakehi y. Int J Clin Oncol. 2021 Apr;26(4):753-763. doi: 10.1007/s10147-020-01850-3. Epub 2021 Feb 11. Int J Clin Oncol. 2021. PMID: 33575828 Free PMC article.
Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis.
Takahashi A, Tsukamoto T, Tobisu K, Shinohara N, Sato K, Tomita Y, Komatsubara S, Nishizawa O, Igarashi T, Fujimoto H, Nakazawa H, Komatsu H, Sugimura Y, Ono Y, Kuroda M, Ogawa O, Hirao Y, Hayashi T, Tsushima T, Kakehi Y, Arai Y, Ueda S, Nakagawa M. Takahashi A, et al. Among authors: kakehi y. Jpn J Clin Oncol. 2004 Jan;34(1):14-9. doi: 10.1093/jjco/hyh005. Jpn J Clin Oncol. 2004. PMID: 15020658
Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer.
Kakehi Y, Kamoto T, Shiraishi T, Ogawa O, Suzukamo Y, Fukuhara S, Saito Y, Tobisu K, Kakizoe T, Shibata T, Fukuda H, Akakura K, Suzuki H, Shinohara N, Egawa S, Irie A, Sato T, Maeda O, Meguro N, Sumiyoshi Y, Suzuki T, Shimizu N, Arai Y, Terai A, Kato T, Habuchi T, Fujimoto H, Niwakawa M. Kakehi Y, et al. Jpn J Clin Oncol. 2008 Feb;38(2):122-8. doi: 10.1093/jjco/hym161. Epub 2008 Feb 12. Jpn J Clin Oncol. 2008. PMID: 18272471
Bladder Cancer Working Group report.
Kakehi Y, Hirao Y, Kim WJ, Ozono S, Masumori N, Miyanaga N, Nasu Y, Yokomizo A. Kakehi Y, et al. Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i57-64. doi: 10.1093/jjco/hyq128. Jpn J Clin Oncol. 2010. PMID: 20870921
Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan.
Nishimura K, Nonomura N, Hashine K, Kanayama HO, Ozono S, Miura T, Miki T, Kakehi Y, Arai Y, Ogawa O, Fujita R, Nonomura K, Mizokami A, Hoshi S, Akaza H. Nishimura K, et al. Among authors: kakehi y. Int J Clin Oncol. 2013 Apr;18(2):306-13. doi: 10.1007/s10147-012-0380-1. Epub 2012 Feb 21. Int J Clin Oncol. 2013. PMID: 22350099 Clinical Trial.
The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort.
Hirama H, Sugimoto M, Ito K, Shiraishi T, Kakehi Y. Hirama H, et al. Among authors: kakehi y. J Cancer Res Clin Oncol. 2014 Feb;140(2):257-63. doi: 10.1007/s00432-013-1566-2. Epub 2013 Dec 19. J Cancer Res Clin Oncol. 2014. PMID: 24352745 Free PMC article.
Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209.
Kitamura H, Tsukamoto T, Shibata T, Masumori N, Fujimoto H, Hirao Y, Fujimoto K, Kitamura Y, Tomita Y, Tobisu K, Niwakawa M, Naito S, Eto M, Kakehi Y; Urologic Oncology Study Group of the Japan Clinical Oncology Group. Kitamura H, et al. Among authors: kakehi y. Ann Oncol. 2014 Jun;25(6):1192-8. doi: 10.1093/annonc/mdu126. Epub 2014 Mar 24. Ann Oncol. 2014. PMID: 24669010 Free article. Clinical Trial.
Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer.
Nozawa M, Mukai H, Takahashi S, Uemura H, Kosaka T, Onozawa Y, Miyazaki J, Suzuki K, Okihara K, Arai Y, Kamba T, Kato M, Nakai Y, Furuse H, Kume H, Ide H, Kitamura H, Yokomizo A, Kimura T, Tomita Y, Ohno K, Kakehi Y. Nozawa M, et al. Among authors: kakehi y. Int J Clin Oncol. 2015 Oct;20(5):1026-34. doi: 10.1007/s10147-015-0820-9. Epub 2015 Mar 26. Int J Clin Oncol. 2015. PMID: 25809824 Clinical Trial.
374 results